Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Barr, J.
Right arrow Articles by Lahat, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barr, J.
Right arrow Articles by Lahat, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMMONIA
*HELIUM
*OXYGEN
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Heliox Use in the Treatment of Acute Hyperammonemia

Joseph Barr, MD

Pediatric Intensive Care Unit

Gideon Eshel, MD

Pediatric Intensive Care Unit

Zehava Chen-Levy, PhD

Department of Clinical Biochemistry

Eli Lahat, MD

Pediatric Neurology Unit Assaf Harofeh Medical Center Zerifin, Israel Sackler Faculty of Medicine Tel Aviv University Tel Aviv, Israel

The objective of this study was to evaluate a new method for the treatment of acute hyperammonemia with a helium-oxygen mixture (heliox). We conducted a prospective, randomized, controlled study of male Sprague-Dawley rats. Experimental hyperammonemia was induced by 7 days of a high-ammonia diet. Subsequently, the animals were randomly divided into two groups: the study group treated with heliox breathing for 24 hours and a control group breathing room air for 24 hours. A prospective, randomized, controlled laboratory animal study was conducted at an animal research facility. The baseline plasma ammonia level was 9.49 ± 10.96 µmol/L. After 7 days of a high-ammonia diet, the plasma ammonia level rose to 31.53 ± 8.86 µmol/L. There was a significant statistical difference between the plasma ammonia level following 24 hours of heliox therapy ( 23.14 ± 13.97 µmol/L) and the ammonia level in the control group (42.31 ± 24.25 µmol/L) (P < .05). Heliox breathing was found to be an efficient treatment modality for decreasing plasma ammonia levels in an animal model. Further studies are required to evaluate its potential application in the treatment of patients with hyperammonemia. (J Child Neurol 2001;16:456-458).

Journal of Child Neurology, Vol. 16, No. 6, 456-458 (2001)
DOI: 10.1177/088307380101600616


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?